***Note to Authors: please make sure your contact address information is clearly visible on the outside of all packages you are sending to Editors.***

Aims and Scope

Renal Failure will publish manuscripts dealing with biochemical, clinical, or therapeutic aspects of uremia. However, the journal will give particular emphasis to papers dealing with all aspects of acute renal failure - experimental models, pathophysiology, prevention and management, basic or clinical studies on renal function in the critically ill, and drug nephrotoxicity.

Submission of Manuscripts

Manuscripts should be submitted to Renal Failure's Electronic Submissions and Peer Review Website: http://mc.manuscriptcentral.com/lrnf

We prefer to receive electronic files in Microsoft Word for the PC. Please submit all elements of your article - text, references, low-resolution figures, captions, and tables as separate documents. Name the Word files as: Renal Failure plus the last name of the lead author, the word Draft, and the date as six digits (Example: RenalFailure_Smith_Draft_051504).

Journal article contributors release the copyright of their article to Informa Healthcare on signature of the Copyright Release Form; forms can be obtained by visiting http://mc.manuscriptcentral.com/lrnf, under the listing for Forms and Instructions. Please note that these forms are required and must be signed and submitted during upload of the manuscript. We recognize that Government employees may not be authorized to release the copyright of their article. Authors are responsible for obtaining permission to reproduce copyrighted material from other sources. All accepted manuscripts, artwork, and photographs become the property of the publisher.

Please number manuscript pages consecutively throughout the paper. Authors should also supply a shortened version of the title suitable for the running head, not exceeding 50 character spaces. Each article should be summarized in an abstract of not more than 100 words.

Peer Review

The Corresponding Author should recommend 3 potential reviewers upon submission of their manuscript. A proper e-mail address is required for each reviewer. All manuscripts are transmitted electronically for peer reviews. Peer reviewer identities are kept confidential, but the reviewers know author identities. Once the review process is completed successfully, authors will be notified of acceptance and given further instructions for submitting final files. Rejected manuscripts will not be returned to the author.

Declaration of interest

It is the policy of all Informa Healthcare, to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE). (http://www.icmje.org/index.html#conflict)

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and where available within the appropriate field on the journal's Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.

If no conflict is declared, the following statement will be attached to all articles:

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.

Required Content

Article Type: Select one from the following list and include as a heading above your article: Clinical Study, Laboratory Study, Case Report, Brief Report, Letter to the Editor, State-of-the-Art-Review.

Article Title: Maximum length 100 characters.

Author Data: Full name, affiliation, mailing address, e-mail, and fax for each contributor. E-mail addresses are required for each author of a manuscript.

Corresponding Author: Identify the corresponding author and give the preferred e-mail address for receiving correspondence and proofs and preferred mailing address to receive complimentary material.

Key Words: Four to six words or phrases - preferably MdSH (Medical Subject Heading) terms, the controlled vocabulary used by PubMed - that describe the main topics of your article.

Abstract: One paragraph (250 words maximum)summarizing the content of your article (i.e. rational, objectives, main findings, and principle conclusions). Do not include headings, abbreviations, footnotes, or acronyms. Do not cite references, figures, or tables.

Introduction: One or two paragraphs providing background material, the rational for the study, and the hypothesis or central questions. The ideal length is 500 words.

Right Running Head: A shortened version of the title, no longer than 50 characters, suitable to run at the top of the right pages of the article.

Required Heading and Length: Original Research or Review Articles: All required headings are: Abstract, Introduction, Materials and Methods, Results, Discussion, Reference. Grants, funding, previous publication, etc... are footnoted on the first page of the article.

Acknowledgements: Acknowledgements are grouped into one paragraph after the discussion.

Case report: These follow the same format as Original Research or Review Articles, but are limited to approximately 2,000 words.

Brief Reports, Letters to the Editor, and State-of-the-Art Reviews: Send a proposal to Editor Dr. Finn before completion or submission of the article. Include a description of scope, novel aspect, and tentative contents of the proposed article. Brief Reports and Letters to the Editor must be of practical value to physicians; personal opinions, when fully supported by data, may be included. State-of-the-Art articles are comprehensive, scholarly works of longer length (24-40 pages; 5000-10000 words).

References: Follow the American Medical Association Manual of Style, 9th Edition.
Journals: List all authors if six or less, otherwise list three, followed by et al. in inverted style; full article title; jounal with standard abbreviation; year of publication, volume number, issue number, inclusive page numbers. Example:
Raux H, Coulon P, Lafay F, Flamand A. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. Virology. 1995;210:400-408.
Books: List all chapter authors in inverted style; the title of the chapter; editors of the book in inverted style if applicable; the name of the book, city and state of the publisher, name of the publisher, year of publication, inclusive page numbers. Example:
Degner LF, McWilliams ME. Challenges in conducting cross-national nursing research. In: Fitzpatrick JJ, Stevenson JS, Polis NS, eds. Nursing Research and its Utilization: International State of the Science. New York, NY: Springer; 1994:211-215. Meetings or conferences: Prasad EA, Jackson O. Abstract of papers, Part 2. 212th National Meeting of the American Chemical Society, Orlando, FL, Aug. 25-29, 1996
Electronic Publications: http://publish.aps.org/abstract/PRD/v61/010303 (accessed June 2000).

Illustrations

Illustrations submitted (line drawings, halftones, photos, photomicrographs, etc.) should be digital files of the highest quality reproduction and should follow these guidelines:

• 300 dpi or higher
• sized to fit on journal page
• EPS, TIFF, or PSD format only
• submitted as separate files, not embedded in text files

Color illustrations will be considered for publication; however, the author will be required to bear the full cost involved in their printing and publication. The charge for the first page with color is $1000.00. The next three pages with color are $500.00 each. A custom quote will be provided for color art totaling more than 4 journal pages. Good-quality color prints or files should be provided in their final size. The publisher has the right to refuse publication of color prints deemed unacceptable.

Tables and Figures

Tables and figures should not be embedded in the text, but should be included as separate sheets or files. A short descriptive title should appear above each table with a clear legend and any footnotes suitably identified below. All original figures should be clearly marked in pencil on the reverse side with the number, author's name, and top edge indicated. All units must be included. Figures should be completely labeled, taking into account necessary size reduction. Captions should be typed, double-spaced, on a separate sheet.

Page Proofs

Proofs will be sent out to all authors via e-proofs. Therefore, each author must submit an e-mail address in order to receive e-proofs. All proofs must be corrected and returned to the publisher by the specified deadline. If proofs are not returned by the specified deadline, the manuscript may be pulled from the issue. Only correction of typographical errors is permitted.

Journal Copies

Corresponding authors will each receive one PDF of their article. Offprints and extra journal copies can be ordered at the page proof stage through the publisher.